CytoMed Therapeutics (GDTC) Debt to Equity (2020 - 2025)
CytoMed Therapeutics (GDTC) debt to equity from Mar 31, 2020 to Dec 31, 2025. The current CytoMed Therapeutics (GDTC) debt to equity is 7.34%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of CytoMed Therapeutics (GDTC)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 7.34% | +42.96% |
| 2024 | 5.13% | +28.69% |
| 2023 | 3.99% | -99.44% |
| 2022 | 718.64% | +471.40% |
| 2021 | 125.77% | -79.81% |
| 2020 | 622.92% | +1703.67% |
| 2019 | 34.54% | N/A |
Comparison CytoMed Therapeutics (GDTC) debt to equity with competitors
CytoMed Therapeutics (GDTC) debt to equity is 7.34%.